What is Lifesci Capital’s Forecast for AVDL Q1 Earnings?
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Analysts at Lifesci Capital issued their Q1 2025 earnings per share estimates for shares of Avadel Pharmaceuticals in a research report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti anticipates that the company will post earnings per share of ($0.04) for the quarter. The consensus […]
